Stock data
BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies, Inc. (BRTX) reported revenue of US$0.36M and net income of -US$14.24M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.36M | US$0.34M | -US$15.65M | -US$14.24M | — |
| 2024 | US$0.40M | US$0.37M | -US$11.56M | -US$8.98M | — |
| 2023 | US$0.15M | US$0.15M | -US$15.22M | -US$10.42M | — |
| 2022 | US$0.12M | — | -US$18.97M | -US$18.49M | — |
| 2021 | US$0.05M | — | -US$26.31M | -US$44.30M | — |
Quarterly results
Data as of 2026-03-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-03-31 | US$0.02M | -US$2.15M | — |
| 2025-12-31 | US$0.02M | -US$3.21M | — |
| 2025-09-30 | US$0.01M | -US$3.04M | — |
| 2025-06-30 | US$0.30M | -US$2.66M | — |
| 2025-03-31 | US$0.03M | -US$5.34M | — |
| 2024-12-31 | US$0.04M | -US$1.64M | — |
| 2024-09-30 | US$0.23M | -US$1.09M | — |
| 2024-06-30 | US$0.09M | -US$4.03M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.